# Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors

> **NCT00588276** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 15 (actual)

## Conditions studied

- Cervical Cancer
- HEENT Cancer
- Renal Cancer
- Uterine Cancer
- CERVIX UTERI NOS
- RECTUM

## Interventions

- **RADIATION:** 124I-Iodo-Azomycin Galacto-Pyranoside

## Key facts

- **NCT ID:** NCT00588276
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00588276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00588276, "Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00588276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*